Adrenal Artery Ablation for Uncontrolled Hypertension

Status Recruiting

Clinical Trial Summary

The activation of the renin-angiotensin-aldosterone system (RAAS) plays a key role in uncontrolled hypertension or resistant hypertension. Surgery and and medicine are the main treatment for primary aldosteronism(PA) by the current guidelines. However, only a small part of patients with PA meet the surgical criteria, and most of patients with uncontrolled hypertension and activation of RAAS have to take spironolactone or other antihypertensive drugs for long time. On the other side, long-term inhibition of aldosterone receptor may cause hyperkalemia, male breast hyperplasia and other adverse reactions. Moreover, hyperaldosterone is still not corrected by spironolactone, which causes extensive cerebrovascular damages even though blood pressure and blood potassium had been normalized.

With the development of adrenal vein sampling and adrenal ablation, selective arterial ablation of adrenal gland(AAA) was observed with significant decrease of blood aldosterone and blood pressure in patients with PA, which made it promising that uncontrolled hypertension could be relieved by selective AAA.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03660397
Study type	Interventional
Source	Third Military Medical University
Contact
Status	Recruiting
Phase	Phase 3
Start date	August 1, 2018
Completion date	January 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01939392` - Rapid Renal Sympathetic Denervation for Resistant Hypertension II	Phase 2/Phase 3
Terminated	`NCT01966952` - Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension	N/A
Completed	`NCT01699529` - Multi-electrode Radiofrequency Renal Denervation System Feasibility Study	N/A
Completed	`NCT01418261` - SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension	N/A
Completed	`NCT01635998` - Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation	N/A
Completed	`NCT02674464` - Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)	N/A
Completed	`NCT04809519` - Integrative Nursing Based Multimodal Interventions for Uncontrolled Hypertensives	N/A
Completed	`NCT01996033` - EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
Terminated	`NCT01628198` - Impact of Renal SympAthetic DenerVation on Chronic HypErtension	N/A
Recruiting	`NCT03221114` - Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease	N/A
Completed	`NCT04248530` - DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study	N/A
Recruiting	`NCT06034743` - A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension	Phase 3
Completed	`NCT02006758` - Observational Study of the EnligHTN Renal Denervation System in Europe
Active, not recruiting	`NCT03209154` - An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment	N/A
Withdrawn	`NCT05352425` - Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension	N/A
Not yet recruiting	`NCT06336356` - A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension	Phase 2
Completed	`NCT05395403` - Use of Automated Office Blood Pressure Monitoring	N/A
Recruiting	`NCT05732727` - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease	Phase 3
Completed	`NCT02418091` - Integrated Population Program for Diabetic Kidney Disease	N/A
Not yet recruiting	`NCT05234788` - Renal Artery DenervatIon Using Radial accesS in Uncontrolled HyperTensioN	N/A